Related references
Note: Only part of the references are listed.Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Jens Y. Humrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Circulating Follicular Helper-Like T Cells in Systemic Lupus Erythematosus
Jin-Young Choi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
David Klatzmann et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure
Jing He et al.
IMMUNITY (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Clinical associations of serum interleukin-17 in systemic lupus erythematosus
Fabien B. Vincent et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
Andre Ballesteros-Tato et al.
IMMUNITY (2012)
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Zheng Liu et al.
NATURE MEDICINE (2012)
Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells
Min S. Shin et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
Linda A. Lieberman et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
T cells as therapeutic targets in SLE
Jose C. Crispin et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
Richard A. Furie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus
Ji Yang et al.
ARTHRITIS AND RHEUMATISM (2009)
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2008)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
